Overview

Everolimus in Treating Older Patients With Mantle Cell Lymphoma Previously Treated With First-Line or Second-Line Chemotherapy

Status:
Terminated

Trial end date:
2014-09-01

Target enrollment:

Participant gender:

Summary

RATIONALE: Everolimus may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. PURPOSE: This phase II trial is studying how well everolimus works in treating older patients with mantle cell lymphoma who received previous first-line or second-line chemotherapy.

Phase:

Phase 2

Details

Lead Sponsor:

Technische Universität München

Treatments:

Everolimus
Sirolimus